Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Belimumab may cause hair loss in lupus patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Belatacept may be a promising treatment for alopecia areata.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Dupilumab may help regrow hair in people with severe alopecia.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib is effective and safe for treating severe alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Canakinumab's effect on COVID-19 outcomes is unclear.